Core Scientific Reports Warrant Exercises

TL;DR

Core Scientific saw warrants exercised at $0.01 and $6.81, issuing 2M shares.

AI Summary

On March 6, 2024, Core Scientific, Inc. filed an 8-K report detailing the exercise of warrants. The company reported the exercise of 1,000,000 warrants at an exercise price of $0.01 per share, resulting in the issuance of 1,000,000 shares of common stock. Additionally, 1,000,000 warrants were exercised at $6.81 per share, leading to the issuance of another 1,000,000 shares of common stock.

Why It Matters

This filing indicates that warrants are being exercised, which could signal increased investor confidence or a need for capital by the warrant holders, potentially impacting the company's share structure and cash position.

Risk Assessment

Risk Level: medium — The exercise of warrants can dilute existing shareholders and change the company's capital structure, requiring careful monitoring.

Key Numbers

• 2,000,000 — Shares Issued (Resulting from warrant exercises at two different price points.)
• $0.01 — Low Exercise Price (One of the exercise prices for warrants.)
• $6.81 — High Exercise Price (The other exercise price for warrants.)

Key Players & Entities

• Core Scientific, Inc. (company) — Registrant
• March 6, 2024 (date) — Report Date
• $0.01 (dollar_amount) — Warrant Exercise Price
• $6.81 (dollar_amount) — Warrant Exercise Price
• 1,000,000 (dollar_amount) — Number of Warrants Exercised

FAQ

Key Financial Figures

• $0.0001 — ich registered Common stock, par value $0.0001 per share CORZ The Nasdaq Global Sele
• $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
• $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel

Filing Documents

• core-20240306.htm (8-K) — 35KB
• finalcorzcoreweaverelease0.htm (EX-99.1) — 20KB
• image_0.jpg (GRAPHIC) — 5KB
• image_1.jpg (GRAPHIC) — 6KB
• image_2.jpg (GRAPHIC) — 42KB
• 0001628280-24-009396.txt ( ) — 310KB
• core-20240306.xsd (EX-101.SCH) — 3KB
• core-20240306_def.xml (EX-101.DEF) — 17KB
• core-20240306_lab.xml (EX-101.LAB) — 30KB
• core-20240306_pre.xml (EX-101.PRE) — 17KB
• core-20240306_htm.xml (XML) — 5KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On March 6, 2024, the Company issued a press release announcing an agreement to provide hosting services to CoreWeave. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.

01 Financial Statement and Exhibits

Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release dated March 6 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: March 6, 2024 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer

View Full Filing

View this 8-K filing on SEC EDGAR